Dr. Anna Ossami Saidy, a specialist in Haematology and Cell Therapy at Helios Hospital Berlin-Buch, Germany, has been awarded the Jian-Jian Luan Award. This prestigious recognition from the European Society for Blood and Marrow Transplantation (EBMT) honors her abstract's selection and highlights her contributions to the field.
Dr. Saidy's research focuses on comparing the efficacy and toxicity of two approved anti-cluster of differentiation (CD)19 CAR-T cell therapies: axi-cel and liso-cel. This comparative analysis, conducted using data from the EBMT, aims to provide crucial insights for physicians making clinical decisions in the second-line treatment of large B cell lymphoma.
Her work is expected to significantly impact patient treatment courses by enabling more informed product selection. Dr. Saidy emphasized that the achievement is a collective effort, involving statisticians, data managers, contributing centers, and most importantly, the patients who share their data.
Inspired by the rapid advancements in aggressive lymphoma treatments and the dynamic nature of the field, Dr. Saidy finds motivation in collaboration and mentorship within the EBMT community. She advises young investigators to seek mentorship and engage with collaborative groups like EBMT to make a meaningful impact.